Scott examines the Metaculus Threat To Democracy Index, which uses crowdsourced forecasting to measure democratic health, discussing its advantages over traditional expert-based indices and its vulnerabilities to manipulation and selection bias. Longer summary

Scott discusses the Metaculus Threat To Democracy Index, a new approach to measuring American democratic health using crowdsourced forecasting rather than expert opinion. The index aggregates 153 questions about democratic threats (like election cancellations or ballot access) weighted by forecasters' historical accuracy. Scott analyzes its advantages—transparency, resistance to ideological bias, and ability to measure probabilities rather than binary outcomes—alongside its risks, including susceptibility to crowd attacks, bot manipulation, and question selection bias. He finds the recent data somewhat reassuring (showing no expected worsening during Trump's term) and suggests the index will become more valuable over time as question biases become less relevant. Shorter summary

Scott argues that Trump supporters and conservative-aligned people who push back on bad administration policies should be supported rather than pressured to publicly denounce Trump, as they're often the only ones who can effectively prevent worse outcomes. Longer summary

Scott argues that Trump administration officials who maintain credibility with the administration while pushing back on bad policies are a valuable resource that should be supported rather than condemned. He explains how the Trump administration ignores liberal criticism but sometimes listens to loyal Republicans and Trump supporters, making these 'thoughtful collaborators' crucial for preventing worse outcomes. The post defends people who work within conservative institutions or refrain from publicly denouncing Trump while privately working to improve policy, arguing that demanding they explicitly condemn the administration would eliminate their effectiveness. Scott addresses concerns about collaboration legitimizing the administration by noting that voters are too uninformed and polarized for policy details to significantly affect political outcomes, making the real-world benefits of good policy more important than theoretical electoral effects. Shorter summary

Scott analyzes the Pentagon's threatening tactics against Anthropic for refusing to remove Usage Policy restrictions from their contract, arguing this represents unprecedented authoritarian overreach and supporting Anthropic's stance against mass surveillance. Longer summary

Scott discusses a contract dispute between Anthropic and the Pentagon, where the Pentagon is attempting to renegotiate their original agreement to remove Anthropic's Usage Policy restrictions and gain access to AI for 'all lawful purposes.' Anthropic has resisted, requesting guarantees against mass surveillance of American citizens and autonomous killbots, which the Pentagon refused. The Pentagon has threatened various consequences including designating Anthropic a 'supply chain risk'—an unprecedented use of a designation previously only applied to foreign adversaries. Scott argues strongly in support of Anthropic's position, viewing the Pentagon's tactics as authoritarian overreach. He addresses numerous counterarguments in detail, explains why the Pentagon should simply switch to another AI vendor, and praises the widespread support Anthropic has received from across the political spectrum and the tech industry. Shorter summary

Scott shares 50 diverse links covering topics from AI developments to policy changes, with commentary on current events, research findings, and societal trends. Longer summary

In this monthly links roundup, Scott Alexander covers a wide range of topics including AI developments, public policy changes, scientific research, and current events. The post follows a numbered format presenting each item with Scott's characteristic analysis and often humorous commentary. Notable topics include AI safety developments, changes in government policy, climate change updates, and various social and technological trends. The tone alternates between analytical and personal reflection, particularly when discussing potentially concerning political developments. Shorter summary

Elizabeth Van Nostrand explains how the International Refugee Assistance Project's (IRAP) ground-level work with refugees enabled a rapid response to Trump's immigration ban, highlighting the importance of maintaining emergency response capacity. Longer summary

This guest post by Elizabeth VanNostrand discusses the importance of organizations like the International Refugee Assistance Project (IRAP) in responding to crises such as Trump's immigration ban. The author explains how IRAP's day-to-day work with individual refugee cases positioned them to respond quickly and effectively when the ban was implemented. The post highlights the value of maintaining capacity for emergency response, even when it may seem inefficient during non-crisis periods. It also emphasizes the importance of partnerships between organizations like IRAP and larger, more established groups like the ACLU. The author concludes by encouraging donations to IRAP or similar small charities doing ground-level work. Shorter summary

Scott Alexander discusses potential Trump administration health-related appointments, focusing on FDA commissioner candidates Jim O'Neill and Balaji Srinivasan, and their potential to implement beneficial reforms. Longer summary

Scott Alexander discusses potential Trump administration picks for key health-related positions, particularly the FDA commissioner and NIH chief. He expresses excitement about the possibility of Jim O'Neill or Balaji Srinivasan being chosen for FDA commissioner, viewing them as principled libertarians who could implement beneficial reforms. Alexander outlines several policies these candidates might pursue, such as medical reciprocity with other countries and streamlining generic drug approvals. He also mentions John Ioannidis as a surprising potential pick for NIH chief, praising his work in improving medical research standards. The post concludes by noting that pharmaceutical industry stocks haven't moved much in response to these potential appointments. Shorter summary